HIGHLIGHTS
- who: November et al. from the University ofUnited States have published the research work: Editorial: Novel modalities in cancer diagnostics and therapeutics, in the Journal: (JOURNAL) of 30/Nov/2022
- how: Their results showed that both vanillin derivatives were effective for F. nucleatuminfected Colorectal cancer (CRC) cells by inhibiting proliferation and migration through the E-cadherin/u03b2catenin pathway suggesting potential natural product drug candidates for microbe-targeted strategies for the treatment of CRC.
- future: The aim was to collect the latest findings in both basic research and clinic application to contribute to the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.